Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE +0.02%, DAX (0.09%), CAC40 (0.01%)

Aug 20 ,2026

  • Synopsis

    • European equity markets are set for a mixed open. Asian equities strengthening Thursday. Memory giants underpinning South Korea's outperformance. Greater China and Japan also higher while Taiwan and Australia little changed. S&P 500 futures up slightly afterhours.

    • In central banks, Riksbank interest rate decision at 9:30CET. Expected to leave its benchmark interest rate unchanged at 1.75%. Press conf at 11:00. Norges Bank publishes its latest expectations survey at 10:00CET. Slovak central bank publishes its latest Structural Challenges Report (content includes monitoring the competitiveness of the Slovak economy). Bundesbank releases its latest monthly report at 12noon CET. Netherland central bank's Sleijpen speech in Paramaribo, Surimane.

    • Elsewhere, former UK Chancellor and Foreign Secretary Jeremy Hunt will be in conversation with journalist John Kampfner at Edinburgh Fringe at 17:00BST.

    • Macro data include Germany Jul PPI, Eurozone Jun construction output, Switzerland Jul trade balance (monthly watch stats), UK Aug industrial trends orders - CBI, Denmark Q2 preliminary GDP and Netherlands Jul unemployment rate

    • Earnings kicked off with Nordic names, Novonesis (NSIS.B.DC), GN Store Nord (GN.DC), Orkla (ORK.NO), Holmen (HOLM.B.SS), ALK-Abelló (ALK.B.DC) and Höegh Autoliners (HAUTO.NO), while Novonesis also raised its FY26 organic sales growth outlook and ALK-Abelló updated its FY outlook. In Benelux, Aegon (AGN.NA) and Ackermans & Van Haaren (ACKB.BB) were among the main companies reporting. Elsewhere, Swiss Prime Site (SPSN.SW) and UNIQA Insurance Group (UQA.AV) released results.

  • Politics/Macro/World News

    • UK finally showing signs of productivity boost, say economists - FT

    • Netherlands Jul Unemployment Rate 4.0% vs consensus 3.9% and prior 3.8%

  • Top company news

    • Earnings/updates

      • Benelux:

        • BTLS.BB (Biotalys) -- reports H1 normalised net loss (€7.2M) vs year-ago (€8.1M)

        • ACKB.BB (Ackermans & Van Haaren) -- reports H1 EPS (€0.23) vs year-ago (€0.22)

        • AGN.NA (Aegon) -- reports H1 Operating capital generation (after holding funding & op. exp.) €416M vs consensus €377.4M; on track to meet or exceed all Group financial ambitions for 2026

        • KIN.BB (Kinepolis Group) -- reports H1 net income €25.3M vs FactSet €20.8M [2 est, €17.9-23.6M]

      • DACHs:

        • NFN.GR (NFON) -- confirms prelim Q2 results and updated FY26 guidance as of 13-Aug

        • SPSN.SW (Swiss Prime Site) -- reports H1 FFO CHF2.15 vs year-ago CHF2.10

        • BCVN.SW (Banque Cantonale Vaudoise) -- reports H1 net income CHF225.0M vs FactSet CHF220.6M [1 est]

        • SBO.AV (SBO AG) -- reports H1 EPS €0.01 vs year-ago €1.18

        • UQA.AV (UNIQA Insurance Group) -- reports H1 net income €258M; well on track to achieve FY earnings before taxes target

        • TNIE.GR (tonies) -- reports Q2 revenue €242.9M vs FactSet €106.4M [4 est, €95.1-112.8M]

        • MMK.AV (Mayr-Melnhof Karton) -- reports H1 EPS €1.60; increases P&L benefit target from the Fit-For-Future program

      • Nordics:

        • ENDUR.NO (Endur ASA) -- reports Q2 EPS NOK1.22 vs FactSet NOK1.43 [7 est, NOK1.07-2.25]

        • B2I.NO (B2 Impact) -- reports Q2 EPS NOK0.66 vs FactSet NOK0.49 [3 est, NOK0.46-0.56]

        • CAT.B.SS (Catella) -- reports Q2 EPS (SEK0.14) vs year-ago SEK3.62

        • VIVA.SS (Viva Wine Group) -- reports Q2 EPS SEK0.45 vs FactSet SEK0.41 [2 est, SEK0.40-0.41]

        • NANOFH.FH (Nanoform Finland) -- reports Q2 EPS (€0.04) vs FactSet (€0.04) [2 est, (€0.04)-(0.04)]

        • NKR.NO (Nekkar) -- reports Q2 EPS NOK0.01 vs FactSet NOK0.06 [2 est, NOK0.05-0.07]

        • NORCO.NO (Norconsult) -- reports Q2 EPS NOK0.43 vs FactSet NOK0.53 [9 est, NOK0.43-0.64]

        • NSIS.B.DC (Novonesis) -- reports Q2 net income €171.7M vs consensus €182M; raises FY26 organic sales growth outlook to 7-8% from 5-7% and expects adjusted EBITDA margin at higher end of 37-38% range

        • GN.DC (GN Store Nord) -- reports Q2 adj EBITA DKK110M vs consensus DKK110.0M; revenue DKK2.17B vs consensus DKK2.15B

        • ORK.NO (Orkla) -- reports Q2 EPS NOK1.60 ex-items vs FactSet NOK1.59 [8 est, NOK1.44-1.68]

        • NEWA.B.SS (New Wave Group) -- reports Q2 EPS SEK1.52 vs FactSet SEK1.49 [6 est, SEK1.45-1.56]

        • SYNACT.SS (SynAct Pharma) -- reports Q2 EPS (SEK0.39) vs year-ago (SEK0.56)

        • TCM.DC (TCM Group) -- reports Q2 net income DKK16.7M vs FactSet DKK23.7M [3 est, DKK20-28M]

        • VISTN.NO (Vistin Pharma) -- reports Q2 EPS NOK0.32 vs year-ago NOK0.42

        • KAR.SS (Karnov Group) -- reports Q2 EPS SEK0.37 vs FactSet SEK0.47 [2 est, SEK0.40-0.53]

        • GREAT.SS (Greater Than) -- reports Q2 EPS (SEK0.74) vs year-ago (SEK0.85)

        • IDEX.NO (IDEX Biometrics) -- reports Q2 net income ($9.0M) vs year-ago ($21.0M)

        • ACE.SS (Ascelia Pharma) -- reports Q2 EPS (SEK0.09) vs year-ago (SEK0.20)

        • KID.NO (Kid ASA) -- reports Q2 EPS NOK0.90 vs FactSet NOK0.93 [6 est, NOK0.70-1.10]

        • FG.SS (Fasadgruppen Group) -- reports Q2 EPS SEK0.70 vs FactSet SEK0.66 [3 est, SEK0.61-0.70]

        • HOLM.B.SS (Holmen) -- reports Q2 EPS SEK3.30 vs FactSet SEK3.24 [9 est, SEK2.79-3.55]

        • ALK.B.DC (ALK-Abelló) -- reports Q2 EPS DKK1.50 vs FactSet DKK1.50 [1 est]; updates FY outlook

        • HAUTO.NO (Höegh Autoliners) -- reports Q2 EPS $0.45 vs FactSet $0.40 [6 est, $0.37-0.46]; Q3 EBITDA expected to be in line with Q2

        • GUBRA.DC (Gubra A/S) -- reports Q2 EBIT (DKK80.8M) vs year-ago DKK2.26B

    • M&A

      • ESSITY.B.SS (Essity) -- to acquire Kenvue's feminine care business in Brazil for SEK2.7B

      • OLE.SM (Deoleo) -- Deoleo's majority shareholder and partners of Holding, S.L. are analyzing possible strategic alternatives regarding their investment (10:38ET)

      • EQT.SS (EQT AB) -- EU sets a provisional deadline of 23-Sep to rule on EQT's acquisition of Exolaunch

      • MF.FP (Wendel) -- EU sets a provisional deadline of 22-Sep to rule on Henkel's acquisition of Stahl Parent

      • CEC.GR (CECONOMY) -- China's justice ministry says EU is 'abusing' foreign subsidies investigation mechanism in regards to JD's bid for CECONOMY - FT

      • DNO.NO (DNO ASA) -- DNO divests Côte d'Ivoire business to Panoro Energy

      • PEN.NO (Panoro Energy) -- Follow-up: Panoro Energy issues press release on acquisition of Côte d'Ivoire producing asset from DNO

      • SPG.DC (SP Group) -- acquires OGM Moulding Ltd. for and initial £18M on a cash- and debt-free basis (8:42ET)

      • CVW.AU (ClearView Wealth) -- Zurich's scheme to acquire ClearView Wealth implemented

    • Other

      • SKA.B.SS (Skanska) -- has signed a contract with an existing client to build four new data centers in the southeast region of the USA. The contract is worth $1.2B

      • ENI.IM (Eni) -- Transcript Intelligence: Eni at EnerCom Denver Energy Investment Conference

      • NSIS.B.DC (Novonesis) -- board approves share buyback program of up to €1B

      • AGN.NA (Aegon) -- CFO Duncan Russell to step down in April 2027

      • HAG.GR (HENSOLDT) -- HENSOLDT's Kelvin Hughes LLC awarded max $57.3M Defense Logistics Agency contract

      • Drive TN consortium selected as best value proposer to deliver Tennessee's I-24 Choice Lanes

      • Mitsui & Co. expands customer base and applications for Denmark-produced e-methanol

  • Key rating changes

    • Upgrades

      • JPMorgan upgrades ML.FP, TYRES.FH

      • UBS upgrades DIM.FP, SRT3.GR; downgrades MRK.GR

    • Downgrades

      • SOLB.BB (Solvay) -- hold from buy at Kepler Cheuvreux

      • SAX.GR (Stroeer SE & Co.) -- hold from buy at Kepler Cheuvreux

      • COLUM.DC (Columbus) -- hold from buy at SEB

    • Initiations

      • OROX.IM (Gens Aurea) -- buy at Jefferies

  • Data

    • Nikkei +1.45% to 66271.65

    • Hang Seng +1.28% to 25822.46

    • Shanghai Composite +0.16% to 3900.52

    • S&P futures +7.0 vs prior close of 7729.0

    • €-$ (0.0002) or (0.02%) to 1.1678

    • $-¥ +0.46 or +0.29% to 158.62

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.